Jersey City, NJ, United States of America

Johannah R Moncecchi

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannah R Moncecchi. Retrieved from https://idiyas.com/inventor/johannah-r-moncecchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Jersey City, NJ (US) (2018)
  • Waltham, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Johannah R Moncecchi: Innovator in Beta-3 Agonists

Introduction

Johannah R Moncecchi is a prominent inventor based in Jersey City, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-3 agonists. With a total of 6 patents to her name, her work has been instrumental in advancing medical science.

Latest Patents

Moncecchi's latest patents focus on the "Process for preparing beta 3 agonists and intermediates." This application is directed towards efficient and economical processes for the preparation of beta-3 agonists and their intermediate compounds. The present disclosure highlights the use of ketoreductase (KRED) biocatalyst enzymes in the manufacturing process, showcasing innovative methods that enhance the production of these important compounds.

Career Highlights

Throughout her career, Johannah has been associated with Merck Sharp & Dohme Corporation, where she has played a vital role in research and development. Her expertise in biocatalysis and pharmaceutical processes has positioned her as a key figure in her field.

Collaborations

Moncecchi has collaborated with notable coworkers, including Hallena Strotman and Hongmei Li. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Johannah R Moncecchi's contributions to the field of beta-3 agonists exemplify her dedication to advancing pharmaceutical science. Her innovative approaches and collaborative efforts continue to make a significant impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…